Sort by
Refine Your Search
-
mechanisms. Cutting-edge research models (eg. primary cell/organoid cultures, mouse models and human clinical samples) and technologies (e.g. scRNA-seq, CRISPR) are utilized in the lab. the PI is highly
-
. The ideal postdoctoral candidate will work both independently and in collaboration with members of our lab to work on in vitro cell culture systems and animal models. We are particularly interested in
-
regenerative therapies for spinal cord injury. Our group, fully funded by the National Institute of Health (NIH), develops neuromodulation devices integrating advanced materials science and stem cell therapy
-
independent research on the design and fabrication of neuromodulation devices and the characterization of these devices. Collaborate with lab members to test devices in cell culture and animal model studies
-
animal model experiments including assessing animal behavior, performing surgeries, tissue harvest, pathology and molecular analysis. Participate and observe in cell experiments including cell culture, PCR
-
, planning, and vision-language model (VLM) pipelines. The role includes disseminating results via publications, patents, demos, and grants, in addition to mentoring students and contributing to course modules
-
independently as well as in a team under direction of the principal investigator, and have the ability to communicate in a clear, concise manner orally and in writing. This position is eligible for visa
-
, immunohistochemistry, transcriptomics, proteomics, lipidomics, reproductive and metabolic cell cultures) to meet the needs of the research project which include evaluating gene, protein, and enzymatic activities
-
and focuses on molecular immunology and inflammatory mechanisms. Cutting-edge research models (eg. primary cell/organoid cultures, mouse models and human clinical samples) and technologies (e.g. scRNA
-
and focuses on molecular immunology and inflammatory mechanisms. Cutting-edge research models (eg. primary cell/organoid cultures, mouse models and human clinical samples) and technologies (e.g. scRNA